SI
ROIV icon

Sofinnova Investments’s Roivant Sciences ROIV Stock Holding History

Sofinnova Investments’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-477,995
Closed -$13.2M – 80
2026
Q1 		$13.2M Sell
477,995
-256,587
-35% -$6.59M 0.5% 44
2025
Q4 		$15.9M Sell
734,582
-2,414,688
-77% -$47.6M 0.69% 38
2025
Q3 		$47.6M Buy
3,149,270
+60,456
+2% +$748K 2.61% 12
2025
Q2 		$34.8M Buy
3,088,814
+1,809,304
+141% +$19.6M 2.13% 16
2025
Q1 		$12.9M Buy
+1,279,510
New +$13.8M 0.84% 33
2024
Q3 		– Sell
-1,868,412
Closed -$19.7M – 85
2024
Q2 		$19.7M Buy
1,868,412
+866,708
+87% +$9.5M 1.03% 31
2024
Q1 		$10.6M Buy
+1,001,704
New +$10.8M 0.59% 38

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Sofinnova Investments's ROIV Position: Q2 2026 in Review

Sofinnova Investments sold out of Roivant Sciences (ROIV) in Q2 2026, closing a stake of 477,995 shares — an estimated $13.2M sold.

Sofinnova Investments first reported a position in ROIV in Q1 2024 and held it in 7 quarters. The position peaked at $47.6M in Q3 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Sofinnova Investments reported no remaining Roivant Sciences position as of Q2 2026 after selling out during the quarter.
  • Sofinnova Investments sold 477,995 Roivant Sciences shares in Q2 2026, an estimated $13.2M.
  • Sofinnova Investments first reported a position in Roivant Sciences in Q1 2024 and held it in 7 quarters.
  • Sofinnova Investments's Roivant Sciences position peaked at $47.6M in Q3 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.